Clinical Trials Directory

Trials / Completed

CompletedNCT01082757

Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients

Prevalence of the Mutational Status of KRAS in mCRC in Argentine Patients

Status
Completed
Phase
Study type
Observational
Enrollment
1,524 (actual)
Sponsor
Merck KGaA, Darmstadt, Germany · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

This observational, prospective, multicentric study is being conducted to record the prevalence of KRAS mutations in the Argentine mCRC population.

Detailed description

This is an observational, prospective, non-interventional, single arm, non-comparative, open label, multi-centric, multi-stage study to record the prevalence of KRAS mutations in the Argentine mCRC population. The study is planned to be conducted in 150 centres (50 in each of 3 stages of four months each, enrolling 500 subjects in each stage). Total of subjects: 1500. Demographic information, complete medical history and tumour history related data will be captured in the first visit and if any information is missing, then only another visit will be scheduled. Data captured will be analysed and presented using statistical tools. OBJECTIVES: Primary objective: * To record the prevalence of KRAS mutations in the Argentine mCRC population. Secondary objective: * To record and evaluate certain subject and tumour characteristics for association with KRAS mutational status (country, gender, age, performance status, body mass index (BMI), ethnic origin, personal and family history of malignancy, personal and family history of familial polyposis coli, smoking status, exercise, diet, tumour characteristics/location, site of origin of the tissue sample sent for KRAS testing, first line therapy chosen).

Conditions

Timeline

Start date
2009-06-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2010-03-09
Last updated
2014-07-31

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT01082757. Inclusion in this directory is not an endorsement.